Literature DB >> 8080369

Laparoscopy and colon cancer. Is the port site at risk? A preliminary report.

J M Ramos1, S Gupta, G J Anthone, A E Ortega, A J Simons, R W Beart.   

Abstract

PURPOSE: To quantify the magnitude of the risk for port/extraction site recurrence of laparoscopically resected colon cancer in a defined study population.
METHODS: The data from a prospective laparoscopic bowel surgery registry was used to identify cases of colon cancer that were resected laparoscopically, with a minimum follow-up of 1 year. A questionnaire was sent to the surgeons who performed the procedures.
RESULTS: A total of 252 cases were identified from the registry. Questionnaires were returned in 208 of those cases, a response rate of 82.5%. Three cases of port or extraction site recurrence were noted, two of them associated with diffuse peritoneal carcinomatosis. All the patients had a Dukes' stage C tumor at the time of initial surgery.
CONCLUSIONS: The incidence of port/extraction site recurrence following laparoscopic colon cancer surgery is low. All the recurrences were in patients with Dukes' stage C tumors, and there was diffuse peritoneal carcinomatosis in two of the three cases, suggesting that port/extraction site recurrence may be attributable to the advanced nature of the disease rather than the laparoscopic technique. Longer follow-up and more cases are required to confirm these findings.

Entities:  

Mesh:

Year:  1994        PMID: 8080369     DOI: 10.1001/archsurg.1994.01420330011001

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  29 in total

1.  Study on incisional implantation of tumor cells by carbon dioxide pneumo peritoneum in gastric cancer of a murine model.

Authors:  Hao Wang; Min-Hua Zheng; Hao-Bo Zhang; Jian Zhu; Jian-Rong He; Ai-Guo Lu; Yu-Bao Ji; Min-Jun Zhang; Yu Jiang; Bao-Ming Yu; Hong-Wei Li
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  The learning curve for hand-assisted laparoscopic colectomy: a single surgeon's experience.

Authors:  J-C Kang; S-W Jao; M-H Chung; C-C Feng; Y-J Chang
Journal:  Surg Endosc       Date:  2006-12-09       Impact factor: 4.584

3.  Laparoscopic vs open colectomy for colon cancer: results from a large nationwide population-based analysis.

Authors:  Scott R Steele; Tommy A Brown; Robert M Rush; Matthew J Martin
Journal:  J Gastrointest Surg       Date:  2007-09-07       Impact factor: 3.452

Review 4.  Metabolism and immunology in laparoscopy. First workshop on experimental laparoscopic surgery, Frankfurt, 1997.

Authors:  C N Gutt; C Kuntz; T Schmandra; A Wunsch; P Heinz; N Bouvy; M Bessler; P Sänger; J Bonjer; J Allendorf; C A Jacobi; R Whelan
Journal:  Surg Endosc       Date:  1998-08       Impact factor: 4.584

5.  Port site metastases after a laparoscopic abdominoperineal resection of rectal cancer: report of a case.

Authors:  Osama H Al-Saif; Bodhisatwa Sengupta; Abdul-Wahed N Meshikhes
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

Review 6.  Laparoscopic rectal cancer surgery: where do we stand?

Authors:  Mukta K Krane; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

7.  A laparoscopic high anterior resection for sigmoid cancer with extraction through incarcerated left inguinal hernia repaired with Permacol mesh.

Authors:  William Reginald Joseph Carr; Graham O'Dair
Journal:  BMJ Case Rep       Date:  2012-09-21

Review 8.  Trocar site recurrence in laparoscopic surgery for colorectal cancer.

Authors:  O Zmora; P Gervaz; S D Wexner
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

9.  Minimally invasive surgery for colorectal cancer. Initial follow-up.

Authors:  G C Hoffman; J W Baker; J B Doxey; G W Hubbard; W K Ruffin; J A Wishner
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 10.  The pathogenesis of port-site recurrences.

Authors:  M A Reymond; C Schneider; S Kastl; W Hohenberger; F Köckerling
Journal:  J Gastrointest Surg       Date:  1998 Sep-Oct       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.